Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2026 Jun 24;40(8):1837. doi: 10.1038/s41375-026-03026-w

Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia

Laura Mazzera 1,2, Manuela Abeltino 2, Guerino Lombardi 1, Anna Maria Cantoni 3, Stefano Jottini 3, Attilio Corradi 3, Micaela Ricca 1, Elena Rossetti 2,4, Federico Armando 3,5, Angelo Peli 6, Anna Ferrari 7, Giovanni Martinelli 7,8, Maria Teresa Scupoli 9, Carlo Visco 10, Massimiliano Bonifacio 10, Alessia Ripamonti 11,12, Carlo Gambacorti-Passerini 11,12, Antonio Bonati 2, Roberto Perris 13,14, Paolo Lunghi 13,14,✉
PMCID: PMC13421321  PMID: 42342852

Retraction Note to: Leukemia 10.1038/s41375-023-01940-x, published online 29 June 2023

The authors have retracted this article. After publication, concerns were raised regarding similarities in some of the blots presented in Figs. 2 and 5. The authors have checked the data and found that a number of blots were incorrectly selected for the figures.

The authors intend to submit a revised version of the manuscript for peer review in due course.

Author Anna Maria Cantoni is deceased. All other authors agree with this retraction.


Articles from Leukemia are provided here courtesy of Nature Publishing Group

RESOURCES